2017
DOI: 10.1038/nchem.2707
|View full text |Cite
|
Sign up to set email alerts
|

Structural and functional synthetic model of mono-iron hydrogenase featuring an anthracene scaffold

Abstract: Mono-iron hydrogenase was the third type of hydrogenase discovered. Its Lewis acidic iron(II) centre promotes the heterolytic cleavage of the H-H bond and this non-redox H activation distinguishes it from the well-studied dinuclear [FeFe] and [NiFe] hydrogenases. Cleavage of the H-H bond is followed by hydride transfer to the enzyme's organic substrate, HMPT, which serves as a CO 'carrier' in methanogenic pathways. Here we report a scaffold-based synthetic approach by which to model mono-iron hydrogenase using… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
60
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 53 publications
(60 citation statements)
references
References 32 publications
0
60
0
Order By: Relevance
“…However, the Fe‐acyl moiety was prone to decomposition via decarbonylation so that catalysis could not be achieved. Two Fe models supported by an anthracene‐bridged NCS ligand could also activate H 2 . Notably these two models contained a carbamoyl donor, instead of the acyl donor found in the enzyme.…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…However, the Fe‐acyl moiety was prone to decomposition via decarbonylation so that catalysis could not be achieved. Two Fe models supported by an anthracene‐bridged NCS ligand could also activate H 2 . Notably these two models contained a carbamoyl donor, instead of the acyl donor found in the enzyme.…”
Section: Figurementioning
confidence: 99%
“…In this context, we examined the hydrogenation of substrates similar to the native substrate of [Fe]‐hydrogenase, namely, methenyl‐H 4 MPT + . The hydrogenation of the 1,3‐bis(2,6‐difluorophenyl)‐2‐(4‐tolyl)imidazolinium cation (in its bromide salt 9 a ), a previously reported model of methenyl‐H 4 MPT + , was first tested. After optimizing conditions (see Table S2 in the Supporting Information), we obtained a yield of 92 % for the hydrogenation of 9 a to generate 10 a using 2.5 mol % of 5 as catalyst (Scheme ).…”
Section: Figurementioning
confidence: 99%
“…We previously reported using a1 ,8-anthracene scaffold bearing at hioether moiety in af unctional modeling study (H 2 activation, H-D scrambling,a nd CÀH hydride abstraction-but no hydride transfer). [9] Thep roposed structure was supported by spectroscopy and theoretical calculation, [9,11] but direct structural evidence (X-ray) for the fac-CNS chelating motif remained elusive.H erein, we report the structural characterization of as ynthetic model derived from the anthracene scaffold that exhibits H 2 activation and hydride transfer activity.…”
Section: Functional Hydride Transfer By Athiolate-containing Model Ofmentioning
confidence: 99%
“…[8] We reasoned that an asymmetric anthracenebased ligand could support af acial set of biomimetic donors (Figure 1, right). [9] Thep roposed structure was supported by spectroscopy and theoretical calculation, [9,11] but direct structural evidence (X-ray) for the fac-CNS chelating motif remained elusive.H erein, we report the structural characterization of as ynthetic model derived from the anthracene scaffold that exhibits H 2 activation and hydride transfer activity. [9] Thep roposed structure was supported by spectroscopy and theoretical calculation, [9,11] but direct structural evidence (X-ray) for the fac-CNS chelating motif remained elusive.H erein, we report the structural characterization of as ynthetic model derived from the anthracene scaffold that exhibits H 2 activation and hydride transfer activity.…”
mentioning
confidence: 99%
“…[9,10] Thek ey breakthrough herein is the inclusion of the aryl thiolate with abulky dimethylphenyl unit at the ortho position to maintain mononuclearity.T he bulky synthon was prepared by base-catalyzed ring-opening of 2-amino-6-bromobenzothiazole followed by treatment with MeI. Thea symmetric aminopyridine synthon Anth·py NH 2 ·Cl was obtained utilizing Pd 2 -(dba) 3 /SPhos as catalyst.…”
mentioning
confidence: 99%